LENSAR (NASDAQ:LNSR) Rating Increased to Hold at Wall Street Zen

LENSAR (NASDAQ:LNSR) was upgraded by Wall Street Zen to a “hold” rating in a report released on Friday.

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of LENSAR in a research note on Wednesday, October 8th. Two research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, LENSAR presently has an average rating of “Reduce” and a consensus target price of $15.00.

LENSAR Trading Down 1.7%

NASDAQ:LNSR opened at $10.17 on Friday. LENSAR has a 1 year low of $7.13 and a 1 year high of $17.31. The firm’s fifty day simple moving average is $11.48 and its 200 day simple moving average is $12.41. The firm has a market capitalization of $121.43 million, a PE ratio of -2.32 and a beta of 0.49.

LENSAR (NASDAQ:LNSR) last released its earnings results on Thursday, November 6th. The company reported ($0.31) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.23). The firm had revenue of $14.32 million for the quarter, compared to analyst estimates of $17.75 million. LENSAR had a negative return on equity of 737.30% and a negative net margin of 87.12%.

Institutional Trading of LENSAR

Institutional investors and hedge funds have recently modified their holdings of the company. Goldman Sachs Group Inc. bought a new stake in LENSAR in the 1st quarter valued at $546,000. Deltec Asset Management LLC acquired a new stake in shares of LENSAR during the 2nd quarter valued at about $428,000. Cubist Systematic Strategies LLC bought a new stake in LENSAR in the first quarter valued at about $369,000. Credit Industriel ET Commercial raised its position in LENSAR by 98.4% in the second quarter. Credit Industriel ET Commercial now owns 168,600 shares of the company’s stock worth $2,220,000 after purchasing an additional 83,600 shares in the last quarter. Finally, Draper Asset Management LLC boosted its holdings in LENSAR by 4.9% during the second quarter. Draper Asset Management LLC now owns 41,985 shares of the company’s stock valued at $536,000 after purchasing an additional 1,945 shares in the last quarter. 40.15% of the stock is currently owned by institutional investors.

LENSAR Company Profile

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.